Table 4.
Expression of Genes | Associated Factor | p Value |
---|---|---|
BCL2L1, BID, BOK, HRK | BRCA2_status, RUNX1_status | 4.145 × 10−10 *** 0.04287 * |
BCL2L1, BID, BOK, HRK | BRCA2 status | 2.106 × 10−9 *** |
BCL2L1, BID, HRK | RUNX1 status | 0.0002187 *** |
BCL2L10, BCL2L2, HRK | HNRNPU status | 8.038 × 10−7 *** |
BCL2L1, BBC3, BOK, BCL2L10, BCL2L11 | HNRNPH2 status | 1.129 × 10−5 *** |
BCL2L11, BCL2L13, BID, BIK, BNIP1 | WBC count | 6.459 × 10−5 *** |
HRK, BAK1, BCL2A1, BID, BNIP1 | SNRNP200 status | 0.002168 ** |
BCL2L10, BNIP2 | DDX42 status | 0.000545 *** |
BCL2, BCL2A1, BCL2L10, BID, BNIP1, MCL1 | CWC27 status | 0.007744 ** |
BMF, RTL10, BAX, BCL2L11, BCL2L2 | CEBPA status | 0.00383 ** |
BCL2L13, BIK, PMAIP1 | RBMX status | 0.0004931 *** |
MCL1, BCL2L11 | HNRNPUL1 status | 0.05703 |
BCL2L2.PABPN1, BNIP2 | DHX38 status | 0.009772 ** |
BCL2, BCL2L11, BCL2L12, BCL2L15 | EP300 status | 0.04793 * |
BCL2L13, BCL2L2, BIK | ATM status | 0.003997 ** |
BAX, BCL2A1, BNIP2 | KRAS status | 0.01254 * |
BCL2L13, BCL2L2 | DNMT3A status | 0.02401 * |
BNIP1, BCL2L2.PABPN1 | IDH1 status | 0.01978 * |
BBC3, BCL2L1, BCL2L11, BOK, MCL1 | IDH2 status | 0.02641 * |
BCL2L1, BOK |
IDH2 status, MCL1 status |
0.001286 ** 0.007325 ** |
BCL2L1, BOK |
IDH2 status, MCL1 status, BRCA2 status |
1.755 × 10−5 *** 4.508 × 10−5 *** 4.624 × 10−6 *** |
BCL2L1, BOK | MCL1 status | 0.001242 ** |
BAD, BAK1, BCL2L11, BID, BNIP2, BNIP3 | RUNX1-RUNX1T1 status | 0.002101 ** |
BCL2L13, BID, BIK, BNIP1 | NPM1 status | 0.02555 * |
BAD, BAX, BCL2L1, BCL2L11, BCL2L13, BCL2L2.PABPN1, BID, BIK, BNIP1, BOK | Blast percentage in PB | 0.003099 ** |
BCL2L1, BCL2L11, BCL2L15, BCL2L2.PABPN1, BID, BIK, BNIP1, BOK, HRK | Blast percentage in BM | 0.000261 *** |
BAK1, BBC3, BCL2L1, BCL2L11, BCL2L12, BOK | Tissue type (PB, BM) | 0.0004833 *** |
BCL2L15, BCL2L2, BNIP1, BNIP3 | FAB type (M1, M2) | 0.03326 * |